Sensing for effective endovascular procedures

The Company

Medyria is a Swiss medtech startup that engineers technologies for

endovascular catheter navigation and sensing.

In 2013, Dr. Mauro Sette came with the idea of incubating a project on the tracking of catheters. In 2014, Medyria AG was effectively incorporated and funded. Three years later, in 2017, Medyria AG has successfully developed an innovative and proprietary blood flow velocity measuring catheter.

The TrackCath System is designed to support cannulation during Endovascular Aneurysm Repair procedures.

 

Medyria AG is located in Technopark, Winterthur, Switzerland.

Our goal is to develop devices that enable safer and more effective endovascular procedures.

We develop a unique guiding and sensing medical device based on  proprietary Blood Flow Velocity Sensor technology. 

 

The TrackCath System is designed to be cost-effective and safe during EVAR procedures.

Products

Our team

Valerie Dubois

Quality and regulatory

Gilles Lachkar

CEO

Dr. Mauro M. Sette

CTO & Founder

Anita Di Iasio

R&D

Jarmo Hytönen

R&D

Lukas Ruckstuhl

Production Process Engineer

Premathilaka Himidunge

Production Technician

Mirjana Seidovic 

Production Technician

Maria Maluszynska-Hoffman

PM R&D

Board of directors

Eric le Royer

Gianluigi Berini

Giovanni Leo

Marc Bär

Mauro M. Sette

Contact

Contact

Medyria AG
c/o Technopark


Technoparkstrasse 2c
8406 Winterthur
Switzerland

mail : info@medyria.com

tel :  +41 (0) 52 214 82 82

fax : +41 (0) 52 508 50 65

 
 
 
 

CAUTION - Investigational device. Limited by law to investigational use.